Featuring "Oral is the New IV" presented by Professor Josh Davis and Ms Kristi Kozierowski (AMS pharmacist, John Hunter Hospital) https://t.co/UB53Nf3le2 @HNEHealth@hneccphn#FOAMed
2022 review: IV device associated events remain the major issue with HCA cases. Relatively low proportion due to MRSA; age-adjusted 30d mortality fell in community cases to 7% from 16%, closer to hca mortality (9%). @hneccphn@hnehealth https://t.co/UYHHbeuWUY
New article: VRE acquisition in hospital and its association with hospital antimicrobial usage. It highlights the impact that reduced broad spectrum antimicrobial use had on VRE acquisition https://t.co/ISwaQX3uIY @mdjkf
1/ Reducing hypoxic pneumonia by 29% and pneumonia hospitalisation by 57% will dramatically shape child health in high-incidence countries. This is the power of pneumococcal vaccination. We must do more to ensure equitable access and promote its use.
https://t.co/L8t0TpJaO0
.@ZelenskyyUa's tv address to the Russian (!) people might be the most moving speech that I've ever seen in my entire life. The whole world needs to see, understand and share this crucial Ukrainian message.
#StandWithUkraine#Ukraine#Україна#Russia#Россия